by In2Pharma | Apr 14, 2017 | News
FAMHP On December 27th 2016, the Sunshine Act was adopted in Belgium. It introduces a new transparency obligation applicable to the pharmaceutical and medical devices industries. The legislation requires pharmaceutical manufacturers, importers and distributors, as...
by In2Pharma | Mar 21, 2017 | News
On January 24th 2017, the new Royal Decree on the manufacture and distribution of food supplements containing herbs or herbal preparations was published, adapting the RD of August 29th 1997. The main change concerns the addition of many botanicals from the BELFRIT...
